PHIO PHARMACEUTICALS CORP. Accretion (Amortization) of Discounts and Premiums, Investments
PHIO PHARMACEUTICALS CORP. (PHIO) reported Accretion (Amortization) of Discounts and Premiums, Investments of -$35.00 thousand for the 117-month period ending 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments · last filed 2012-11-13
- PHIO PHARMACEUTICALS CORP. accretion (amortization) of discounts and premiums, investments for the quarter ending 2012-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. accretion (amortization) of discounts and premiums, investments for the quarter ending 2012-06-30 was $0.00.
| Period end | Accretion (Amortization) of Discounts and Premiums, Investments 3 month | Accretion (Amortization) of Discounts and Premiums, Investments 6 month | Accretion (Amortization) of Discounts and Premiums, Investments 111 month | Accretion (Amortization) of Discounts and Premiums, Investments 114 month | Accretion (Amortization) of Discounts and Premiums, Investments 117 month |
|---|---|---|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 117 month − 10-Q 114 month · filed 2012-11-13 | $0.00 derived: sum of 2 quarters · filed 2012-11-13 | -$35.00K 10-Q · filed 2012-11-13 | ||
| 2012-06-30 | $0.00 derived: 10-Q 114 month − 10-Q 111 month · filed 2012-08-14 | -$35.00K 10-Q · filed 2012-08-14 | |||
| 2012-03-31 | -$35.00K 10-Q · filed 2012-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |